Pdcd4, a colon cancer prognostic that is regulated by a microRNA

被引:104
作者
Allgayer, Heike [1 ]
机构
[1] Heidelberg Univ, Dept Expt Surg Mol Oncol Solid Tumors, Collaborat Unit, German Canc Res Ctr,DKFZ Heidelberg,Med Fac Mannh, D-68167 Mannheim, Germany
关键词
Pdcd4; miR-2l; Cancer; Metastasis; Prognosis; CELL-DEATH; 4; TUMOR-SUPPRESSOR PDCD4; RECEPTOR U-PAR; UROKINASE RECEPTOR; PLASMINOGEN-ACTIVATOR; TRANSFORMATION SUPPRESSOR; HUMAN CHOLANGIOCARCINOMA; MESSENGER-RNA; BONE-MARROW; EXPRESSION;
D O I
10.1016/j.critrevonc.2009.09.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The novel tumor suppressor Pdcd4 inhibits neoplastic transformation, tumor progression and translation. Furthermore, we and others have recently shown that Pdcd4 suppresses invasion and intravasation, at least in part by suppressing expression of the invasion-related urokinase receptor (u-PAR) gene via the transcription factors Sp1/Sp3. Nevertheless, relatively little is known about mechanisms that regulate Pdcd4 expression in cancer. MicroRNAs (miRNAs) have been recently discovered and shown to be naturally occurring non-coding RNAs that control gene expression via specific sites within the 3'UTR of target miRNAs. This short review will focus on our recent finding that the microRNA miR-21 posttranscriptionally regulates Pdcd4, as well as invasion, intravasation, and metastasis. Furthermore, we will review the first translational and clinical results concerning the prognostic value of Pdcd4, in particular our own data that show Pdcd4 to be a novel and independent prognostic factor in colorectal cancer, and a potential supportive diagnostic tool for discriminating normal colonic tissues from benign adenomas and colorectal carcinomas. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:185 / 191
页数:7
相关论文
共 79 条
  • [21] DVORAK HF, 1986, NEW ENGL J MED, V315, P1650
  • [22] Oncomirs - microRNAs with a role in cancer
    Esquela-Kerscher, A
    Slack, FJ
    [J]. NATURE REVIEWS CANCER, 2006, 6 (04) : 259 - 269
  • [23] Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells
    Frankel, Lisa B.
    Christoffersen, Nanna R.
    Jacobsen, Anders
    Lindow, Morten
    Krogh, Anders
    Lund, Anders H.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (02) : 1026 - 1033
  • [24] UROKINASE RECEPTOR AND COLORECTAL-CANCER SURVIVAL
    GANESH, S
    SIER, CFM
    HEERDING, MM
    GRIFFIOEN, G
    LAMERS, CBHW
    VERSPAGET, HW
    [J]. LANCET, 1994, 344 (8919) : 401 - 402
  • [25] Programmed cell death protein 4 (PDCD4) acts as a tumor suppressor in neuroendocrine tumor cells
    Göke, R
    Gregel, C
    Göke, A
    Arnold, R
    Schmidt, H
    Lankat-Buttgereit, B
    [J]. GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR DISEASE: MOLECULAR AND CELL BIOLOGICAL ASPECTS, 2004, 1014 : 220 - 221
  • [26] Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21Waf1/Cip1
    Göke, R
    Barth, P
    Schmidt, A
    Samans, B
    Lankat-Buttgereit, B
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2004, 287 (06): : C1541 - C1546
  • [27] THE PRIMARY STRUCTURE OF HIGH MOLECULAR MASS UROKINASE FROM HUMAN-URINE - THE COMPLETE AMINO-ACID-SEQUENCE OF THE A-CHAIN
    GUNZLER, WA
    STEFFENS, GJ
    OTTING, F
    KIM, SMA
    FRANKUS, E
    FLOHE, L
    [J]. HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1982, 363 (10): : 1155 - 1165
  • [28] MicroRNAs as oncogenes
    Hammond, SM
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 2006, 16 (01) : 4 - 9
  • [29] INDIVIDUAL DEVELOPMENT AND UPA-RECEPTOR EXPRESSION OF DISSEMINATED TUMOR-CELLS IN BONE-MARROW - A REFERENCE TO EARLY SYSTEMIC-DISEASE IN SOLID CANCER
    HEISS, MM
    ALLGAYER, H
    GRUETZNER, KU
    FUNKE, I
    BABIC, R
    JAUCH, KW
    SCHILDBERG, FW
    [J]. NATURE MEDICINE, 1995, 1 (10) : 1035 - 1039
  • [30] MicroRNA-21 Regulates the Proliferation and Invasion in Esophageal Squamous Cell Carcinoma
    Hiyoshi, Yukiharu
    Kamohara, Hidenobu
    Karashima, Ryuichi
    Sato, Nobutaka
    Imamura, Yu
    Nagai, Youhei
    Yoshida, Naoya
    Toyama, Eiichiro
    Hayashi, Naoko
    Watanabe, Masayuki
    Baba, Hideo
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (06) : 1915 - 1922